Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167

Watchlist Manager
Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd
HKEX:1167
Watchlist
Price: 1.73 HKD 0.58% Market Closed
Market Cap: 1.4B HKD
Have any thoughts about
Jacobio Pharmaceuticals Group Co Ltd?
Write Note

Intrinsic Value

Jacobio Pharmaceuticals Group Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Jacobio Pharmaceuticals Group Co Ltd stock under the Base Case scenario is 0.98 HKD. Compared to the current market price of 1.73 HKD, Jacobio Pharmaceuticals Group Co Ltd is Overvalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
0.98 HKD
Overvaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Jacobio Pharmaceuticals Group Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Jacobio Pharmaceuticals Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Jacobio Pharmaceuticals Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Jacobio Pharmaceuticals Group Co Ltd

Provide an overview of the primary business activities
of Jacobio Pharmaceuticals Group Co Ltd.

What unique competitive advantages
does Jacobio Pharmaceuticals Group Co Ltd hold over its rivals?

What risks and challenges
does Jacobio Pharmaceuticals Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jacobio Pharmaceuticals Group Co Ltd.

Provide P/S
for Jacobio Pharmaceuticals Group Co Ltd.

Provide P/E
for Jacobio Pharmaceuticals Group Co Ltd.

Provide P/OCF
for Jacobio Pharmaceuticals Group Co Ltd.

Provide P/FCFE
for Jacobio Pharmaceuticals Group Co Ltd.

Provide P/B
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/S
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/GP
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/EBITDA
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/EBIT
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/OCF
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/FCFF
for Jacobio Pharmaceuticals Group Co Ltd.

Provide EV/IC
for Jacobio Pharmaceuticals Group Co Ltd.

Show me price targets
for Jacobio Pharmaceuticals Group Co Ltd made by professional analysts.

What are the Revenue projections
for Jacobio Pharmaceuticals Group Co Ltd?

How accurate were the past Revenue estimates
for Jacobio Pharmaceuticals Group Co Ltd?

What are the Net Income projections
for Jacobio Pharmaceuticals Group Co Ltd?

How accurate were the past Net Income estimates
for Jacobio Pharmaceuticals Group Co Ltd?

What are the EPS projections
for Jacobio Pharmaceuticals Group Co Ltd?

How accurate were the past EPS estimates
for Jacobio Pharmaceuticals Group Co Ltd?

What are the EBIT projections
for Jacobio Pharmaceuticals Group Co Ltd?

How accurate were the past EBIT estimates
for Jacobio Pharmaceuticals Group Co Ltd?

Compare the revenue forecasts
for Jacobio Pharmaceuticals Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jacobio Pharmaceuticals Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jacobio Pharmaceuticals Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jacobio Pharmaceuticals Group Co Ltd compared to its peers.

Compare the P/E ratios
of Jacobio Pharmaceuticals Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jacobio Pharmaceuticals Group Co Ltd with its peers.

Analyze the financial leverage
of Jacobio Pharmaceuticals Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Jacobio Pharmaceuticals Group Co Ltd.

Provide ROE
for Jacobio Pharmaceuticals Group Co Ltd.

Provide ROA
for Jacobio Pharmaceuticals Group Co Ltd.

Provide ROIC
for Jacobio Pharmaceuticals Group Co Ltd.

Provide ROCE
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Gross Margin
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Operating Margin
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Net Margin
for Jacobio Pharmaceuticals Group Co Ltd.

Provide FCF Margin
for Jacobio Pharmaceuticals Group Co Ltd.

Show all solvency ratios
for Jacobio Pharmaceuticals Group Co Ltd.

Provide D/E Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide D/A Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Interest Coverage Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Altman Z-Score Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Quick Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Current Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

Provide Cash Ratio
for Jacobio Pharmaceuticals Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Jacobio Pharmaceuticals Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Jacobio Pharmaceuticals Group Co Ltd?

What is the current Free Cash Flow
of Jacobio Pharmaceuticals Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jacobio Pharmaceuticals Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Jacobio Pharmaceuticals Group Co Ltd

Balance Sheet Decomposition
Jacobio Pharmaceuticals Group Co Ltd

Current Assets 1.1B
Cash & Short-Term Investments 1.1B
Receivables 19.1m
Non-Current Assets 233.5m
Long-Term Investments 18m
PP&E 211.4m
Intangibles 1.2m
Other Non-Current Assets 2.9m
Current Liabilities 179.7m
Accounts Payable 79m
Short-Term Debt 63.8m
Other Current Liabilities 36.9m
Non-Current Liabilities 226.5m
Long-Term Debt 119.7m
Other Non-Current Liabilities 106.8m
Efficiency

Earnings Waterfall
Jacobio Pharmaceuticals Group Co Ltd

Revenue
23.2m CNY
Cost of Revenue
-22.4m CNY
Gross Profit
801k CNY
Operating Expenses
-375.5m CNY
Operating Income
-374.7m CNY
Other Expenses
12.8m CNY
Net Income
-361.9m CNY

Free Cash Flow Analysis
Jacobio Pharmaceuticals Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jacobio Pharmaceuticals Group Co Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
14/100
Profitability
Score

Jacobio Pharmaceuticals Group Co Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jacobio Pharmaceuticals Group Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
59/100
Solvency
Score

Jacobio Pharmaceuticals Group Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jacobio Pharmaceuticals Group Co Ltd

Wall Street analysts forecast Jacobio Pharmaceuticals Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jacobio Pharmaceuticals Group Co Ltd is 3.77 HKD with a low forecast of 3.74 HKD and a high forecast of 3.89 HKD.

Lowest
Price Target
3.74 HKD
116% Upside
Average
Price Target
3.77 HKD
118% Upside
Highest
Price Target
3.89 HKD
125% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Jacobio Pharmaceuticals Group Co Ltd?

Click here to dive deeper.

Dividends

Jacobio Pharmaceuticals Group Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Jacobio Pharmaceuticals Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Jacobio Pharmaceuticals Group Co Ltd Logo
Jacobio Pharmaceuticals Group Co Ltd

Country

China

Industry

Biotechnology

Market Cap

1.4B HKD

Dividend Yield

0%

Description

Jacobio Pharmaceuticals Group Co., Ltd. operates as an investment holding company which engages in research and development of new drugs. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-21. The firm is primarily responsible for the independent discovery and development of innovative tumor therapies. The firm's main drug development projects include JAB-3068 and JAB-3312 clinical stage allosteric SHP2 inhibitors. The firm mainly conducts business within the domestic market.

Contact

BEIJING
Beijing
Building F2, No. 88, Kechuang 6th Street, Beijing Economic-Technological Development Area
www.jacobiopharma.com

IPO

2020-12-21

Employees

213

Officers

Executive Chairman & CEO
Dr. Yinxiang Wang
Executive Director & President of Administration
Ms. Xiaojie Wang
Executive VP & Executive Director
Ms. Yunyan Hu
Vice President of Human Resources
Ms. Tao Yang
Executive VP, Chief Medical Officer and Global Head of R&D
Dr. Andrea Wang-Gillam M.D., Ph.D.
Executive Vice President of Non-Clinical R&D
Ms. Yanping Wang
Show More
Senior Vice President of Information & Data Management
Dr. Haijun Wang
Executive Vice President of Clinical Development
Ms. Yuli Ding
Joint Company Secretary
Ms. Qing Xue
Show Less

See Also

Discover More
What is the Intrinsic Value of one Jacobio Pharmaceuticals Group Co Ltd stock?

The intrinsic value of one Jacobio Pharmaceuticals Group Co Ltd stock under the Base Case scenario is 0.98 HKD.

Is Jacobio Pharmaceuticals Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1.73 HKD, Jacobio Pharmaceuticals Group Co Ltd is Overvalued by 44%.

Back to Top